NCT05461729

Brief Summary

Brief Summary: Cardiac rehabilitation (CR) is a multi-factorial intervention, designed to limit the physiological and psychological effects of cardiovascular disease such as coronary artery disease (CAD), manage symptoms, and reduce the risk of future cardiovascular events. CR is a structured program not only addressing CAD but also comorbidities including hypertension, dyslipidemia, diabetes and obesity as well as other risk factors. CR aims at long-term lifestyle changes to reduce modifiable risk factors, and it's success depends on a large number of interacting variables including biological, psychological and social factors. Recently, the importance of patient-centered approaches to secondary prevention and CR success has been underlined but intra-individual factors and their interactions are not well understood. The TIMELY prospective study aims to collect high-resolution data for data mining and artificial intelligence machine learning models to identify dependencies between factors and predict favorable outcomes of CR. Data collection will include data documented during controlled center-based CR as well as remote-measurement of physical activity data, (central) blood pressure and pulse wave analysis as well as long-term ECG data during a 6-months period after discharge. Follow-up assessments will be performed at least at 6 months and at 12 months after discharge. Events (MACCE) will be collected for up to 10 years. After 2023, the study will be run under the acronym PrädiktoR. Main objectives of the study:

  1. 1.To examine uptake and adherence to a healthy lifestyle (i. e. adherence to CR guidelines in CAD) and the effects on long-term outcomes.
  2. 2.To identify potentially mediating mechanisms and predictive factors for long-term CR success in CAD, also to be used in machine learning models and for the generation of digital twins.
  3. 3.To investigate acceptance of different eHealth components as well as expectations and needs among CAD patents in CR.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,200

participants targeted

Target at P75+ for all trials

Timeline
40mo left

Started Jun 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Jun 2021Aug 2029

Study Start

First participant enrolled

June 1, 2021

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 13, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 18, 2022

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2029

Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

8.3 years

First QC Date

July 13, 2022

Last Update Submit

March 24, 2026

Conditions

Keywords

Cardiac RehabilitationTelemedicineHealthy LifestylePreventive ProgramsArtificial IntelligencePredictive MedicineContinuum of CareMaintenanceAftercareeHealthmHealth

Outcome Measures

Primary Outcomes (3)

  • Change in Cardiorespiratory Fitness (CRF)

    CRF will be measured as maximal oxygen uptake (VO2max) determined by spiroergometry

    Baseline, week 3, week 24, and week 48

  • Change in risk of mortality

    Risk of mortality will be determined using the validated biomarker risk score COROPREDICT

    Baseline, week 3, week 24, and week 48

  • Number of patients with major adverse cardiac and cerebrovascular events (MACCE)

    Number of patients with death, myocardial infarction, stent thrombosis, stroke or transient ischemic attack, urgent revascularization, and major bleeding

    Baseline to week 48, and week 432

Secondary Outcomes (36)

  • Physical activity (PA)

    Baseline, week 3, week 24, and week 48

  • Daily step count

    Baseline to week 24

  • Weekly number and duration of physical activities

    Baseline to week 24

  • Resting heart rate

    Baseline to week 24

  • Sleep duration

    Baseline to week 24

  • +31 more secondary outcomes

Other Outcomes (1)

  • Needs and requirements for eHealth in cardiac rehabilitation

    Week 3

Study Arms (1)

Coronary Artery Disease

Patients with Coronary Artery Disease

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Coronary Artery Disease (CAD) patients participating in phase II Cardiac Rehabilitation (CR).

You may qualify if:

  • Coronary Artery Disease (CAD) patients after myocardial infarction (STEMI/NSTEMI) and/or angioplasty and/or Percutaneous Coronary Intervention (PCI) and/or coronary artery bypass graft surgery who participate in phase II Cardiac Rehabilitation (CR).

You may not qualify if:

  • Incapability to give informed consent
  • Conditions that prevent patients from participation in CR including unstable coronary or cerebrovascular conditions and acute infections

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klinik Königsfeld

Ennepetal, North Rhine-Westphalia, 58256, Germany

RECRUITING

Related Publications (1)

  • Schmitz B, Wirtz S, Sestayo-Fernandez M, Schafer H, Douma ER, Alonso Vazquez M, Gonzalez-Salvado V, Habibovic M, Gatsios D, Kop WJ, Pena-Gil C, Mooren F. Living Lab Data of Patient Needs and Expectations for eHealth-Based Cardiac Rehabilitation in Germany and Spain From the TIMELY Study: Cross-Sectional Analysis. J Med Internet Res. 2024 Feb 22;26:e53991. doi: 10.2196/53991.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Venous Blood

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Study Officials

  • Boris Schmitz, PhD

    University of Witten/Herdecke, Dpt. Rehabilitation Sciences

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Frank C. Mooren, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Primary Researcher Department of Rehabilitation Sciences

Study Record Dates

First Submitted

July 13, 2022

First Posted

July 18, 2022

Study Start

June 1, 2021

Primary Completion (Estimated)

August 31, 2029

Study Completion (Estimated)

August 31, 2029

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations